Manjeet Rao, Ph.D., Awarded NCI, RO1 Grant to Test Efficacy of Novel Drug

January 13, 2020

Dr. Manjeet Rao, Interim Greehey CCRI Deputy Director, was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in cancers. Cancer cells use various mechanisms to manage their survival such as repairing DNA […]

Adam Kosti from Penalva Lab Publishes First, First-Author Paper

January 10, 2020

ELF4 is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State Abstract 13-Cis-retinoic acid (RA) is typically used in postremission maintenance therapy in patients with neuroblastoma. However, side effects and recurrence are often observed. We investigated the use of miRNAs as a strategy to replace RA as promoters of differentiation. miR-124 was identified […]

MISSION MAGAZINE: Tiny molecule has big effect in childhood brain cancer

October 22, 2019

Sometimes small things make the biggest difference. A new study has found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer. This tiny molecule, named MiR-584-5p, is quite efficient in its action. It sensitizes the cancer to chemotherapy and radiation, making it plausible […]

Review article “Challenges and Opportunities for Childhood Cancer Drug Development” co-authored by Drs Kurmasheva and Houghton

October 3, 2019

The review article “Challenges and Opportunities for Childhood Cancer Drug Development” co-authored by Raushan Kurmasheva, Ph.D. and Peter Houghton, Ph.D. has just been published.

WEBINAR: Childhood Cancer Survivorship, Transitioning to Adulthood

September 27, 2019

REPOST from September 25th webinar originally broadcasted, September 25th, 2019 Childhood cancer advocates, families, researchers, and survivors are invited to join us for this Childhood Cancer Awareness Month event. We’ll have a robust discussion about the challenges facing childhood cancer survivors as they transition out of pediatric care and into young adulthood. SPEAKERS: Gregory Aune, […]

September is Women in Medicine Month

September 19, 2019

  As part of the American Medical Association (AMA) “Women in Medicine Month”, we at the Greehey Children’s Cancer Research Institute – UT Health San Antonio would like to take a moment and celebrate the female faculty who have dedicated their careers to childhood cancer.     Christine Aguilar, MD, MPH, Faculty Associate, Greehey Children’s […]